Streamlining drug delivery device development for industrialisation success

Publisher: IGS GeboJagema

Access this content

Your content has been opened.

Please verify you are a human before downloading this content.

Streamlining drug delivery device development for industrialisation success has been emailed to . Entered the wrong email?

Don't see the content in your inbox?
Make sure to check your spam and other messages folders.

Can't get to your email right now?

To complete your registration and access this content, enter the sign-in code sent to your email.

Please enter a valid verification code.

Code sent to:

Also, remember to check in your spam, promotions, and other folders.


Register to access this content


By accessing content on the Plastics News Online Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.

Streamlining drug delivery device development for industrialisation success

In this article, Hans Arts, Chief Sales Officer, Jan-Willem Den Hollander and Ron Cisliek, Director of Business Development – USA, all of IGS GeboJagema, discuss the value of bringing an industrialisation partner on board early in product development and how working with a single manufacturing specialist can preserve insights and learnings throughout the product development lifecycle and deliver additional value and quality.